Home > Disease

scPharmacueticals’ Heart Failure Therapy Approved by US FDA

The US Food and Drug Administration (FDA) of the United States has approved the on-body infusor ‘Furoscix’ for congestive heart failure developed by scpharmaceuticals. With this approval, Furoscix becomes the first self-administered, and subcutaneous loop diuretic for people with worsening heart failure. This infusor delivers generic furosemide that relieves fluid retention

Read More